About

GCSA

An accreditation standard for clinical trial sites set across seven key areas that ensures sponsors, stakeholders and staff deliver a high-quality experience to all stakeholders.

The GCSA accreditation awards sites a quality mark which will attract sponsors by proving credibility, quality and capability.

The accreditation has been developed from decades of industry experience and input from our global advisory board; made up of sponsors, pharmaceutical organisations, CRNs, CROs, NHS Trusts, commercial research organisations and the wider healthcare industry. 

This unique accreditation has been developed by clinical research experts working with process improvement specialists who have both a healthcare and manufacturing background whilst being expert exponents of Lean methodologies. This blend of cross- sector knowledge has allowed the GCSA accreditation to be a robust, forward-thinking assessment process, incorporating best in class tools and techniques.

Our

Mission

To help attract more clinical research to GCSA accredited sites by evidencing high quality, robust and efficient processes that benefit patients, staff, sponsors, CROs and all associated stakeholders.

Our Mission

To help attract more clinical research to GCSA accredited sites by evidencing high quality, robust and efficient processes that benefit patients, staff, sponsors, CROs and all associated stakeholders.

Our forward thinking sites

Global Advisory Board

Elizabeth Edwards
Biomat USA
Samin Saeed
Novartis
John Mellelieu
Pfeizer
Teresa Allen
HRA (Health Research Authority)
Janet Messer
HRA (Health Research Authority)
Sandra Johnson
MMV (Medicines for Malaria Venture) 
Maria Palmer
NHS R&D; Forum
Simon Lewis
LNWUH
Emer MacSweeney
Re:Cognition
Agnieszka Gackowska
Parexel
Karen McIntyre
Syneos Health

A global quality mark for clinical research, designed to evidence the very best sites across the UK and beyond

+44 (0)1628 784906 (UK HQ)
+1 (855) 209 2335 (US Toll Free)